VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years
Clinical trial NCT00995982 · COMPLETED
Trial details
- NCT number
- NCT00995982
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-08
- Primary completion
- 2010-09-03
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.